Saltar al contenido
Merck

Accurate in vivo tumor detection using plasmonic-enhanced shifted-excitation Raman difference spectroscopy (SERDS).

Theranostics (2021-03-24)
Pietro Strobbia, Vanessa Cupil-Garcia, Bridget M Crawford, Andrew M Fales, T Joshua Pfefer, Yang Liu, Martin Maiwald, Bernd Sumpf, Tuan Vo-Dinh
RESUMEN

For the majority of cancer patients, surgery is the primary method of treatment. In these cases, accurately removing the entire tumor without harming surrounding tissue is critical; however, due to the lack of intraoperative imaging techniques, surgeons rely on visual and physical inspection to identify tumors. Surface-enhanced Raman scattering (SERS) is emerging as a non-invasive optical alternative for intraoperative tumor identification, with high accuracy and stability. However, Raman detection requires dark rooms to work, which is not consistent with surgical settings. Methods: Herein, we used SERS nanoprobes combined with shifted-excitation Raman difference spectroscopy (SERDS) detection, to accurately detect tumors in xenograft murine model. Results: We demonstrate for the first time the use of SERDS for in vivo tumor detection in a murine model under ambient light conditions. We compare traditional Raman detection with SERDS, showing that our method can improve sensitivity and accuracy for this task. Conclusion: Our results show that this method can be used to improve the accuracy and robustness of in vivo Raman/SERS biomedical application, aiding the process of clinical translation of these technologies.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Línea celular de carcinoma de vejiga de ratón MB49, MB49 mouse urothelial carcinoma cell line is widely used as an in vitro and in vivo model of bladder cancer.
Sigma-Aldrich
3,3′-Diethylthiatricarbocyanine iodide, 99%